Overview
Status
Active
Registry date
2012-02-27
Share capital
5,000.00 PLN
Registered address
ul. Eugeniusza Kwiatkowskiego 46/12, 35-311 Rzeszów, Poland
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 775 days for 2021), 1 not filed.
- 202511/09/2026
- 2024not filed
- 202320/03/2025
- 202226/09/2024
- 202128/08/2024
- 202029/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 39.35kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -15.77kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 50.62kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 4.31kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Paweł Panaś – President of the Management Board
Manner of representation
Each member of the management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Anna Panaśage 45 | 1 | $135.06 | 10% |
Paweł Panaśage 48 | 9 | $1,215.56 | 90% |
Paweł Panaś and Agnieszka Anna Panaś hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pharmbiopolsp. z o.o. | $99,211.10 | pharmbiopol.com | ||
| Edge Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| Beyond Medical Aesthetics Polskasp. z o.o. | $13,696.94 | bmapolska.pl | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| Grupa Medicalsp. z o.o. | $12,999.72 | grupamedical.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Polidental Tradesp. z o.o. | $9,409.06 | poli.dental | ||
| BIATsp. z o.o. | $2,327.20 | biat.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-08-07 | PKD change (Removed: 6 codes; Added: 9 codes) | |
| 2017-05-09 | Address change (Broniewskiego 7/12, 35-222, Rzeszów → Ul. Eugeniusza Kwiatkowskiego 46/12, 35-311, Rzeszów) | |
| 2017-05-09 | PKD change (Removed: 38 codes; Added: 2 codes) | |
| 2012-02-27 | Entered in the register |
FAQ
The main business activity of Synfarm focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 27, 2012.
The headquarters is located at: ul. Eugeniusza Kwiatkowskiego 46, 35-311 Rzeszów.
The management board consists of: Paweł Panaś (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company's revenue reached USD 39,348.
No, in 2025 the company reported a net loss of USD 15,766.
The largest operating cost category falls under materials and energy. This category amounted to USD 23,047 in 2025, representing 46% of all operating expenses.
Last updated: 2026-09-11
